Ulka N Vaishampayan Selected Research

Ipilimumab

12/2019	First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium.
5/2017	Changing face of metastatic prostate cancer: the law of diminishing returns holds true.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulka N Vaishampayan Research Topics

Disease

30	Neoplasms (Cancer) 11/2023 - 12/2005
28	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 02/2007
22	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 12/2005
15	Carcinoma (Carcinomatosis) 12/2021 - 10/2005
13	Neoplasm Metastasis (Metastasis) 12/2021 - 08/2006
6	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023 - 08/2015
6	Disease Progression 01/2021 - 07/2009
4	Kidney Neoplasms (Kidney Cancer) 09/2023 - 02/2007
3	Pain (Aches) 09/2014 - 07/2009
2	Triple Negative Breast Neoplasms 01/2023 - 01/2023
2	Circulating Neoplastic Cells 01/2022 - 05/2015
2	Melanoma (Melanoma, Malignant) 01/2021 - 11/2007
2	Nausea 01/2017 - 11/2007
2	Fatigue 01/2017 - 09/2014
2	Hand-Foot Syndrome 03/2016 - 07/2010
1	Alopecia (Baldness) 03/2024
1	Heart Diseases (Heart Disease) 11/2023
1	Small Cell Carcinoma 01/2023
1	Neuroendocrine Carcinoma 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2021
1	Adenocarcinoma 01/2021
1	Urologic Neoplasms (Urological Cancer) 10/2020
1	Clear-cell metastatic renal cell carcinoma 01/2020
1	Malignant Mesothelioma 01/2019
1	Pathologic Complete Response 01/2019
1	Mesothelioma 01/2019

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 09/2023 - 07/2009
11	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 10/2005
8	PlatinumIBA 12/2021 - 10/2005
6	Docetaxel (Taxotere)FDA Link 03/2024 - 07/2009
6	AndrogensIBA 01/2023 - 04/2013
6	Everolimus FDA Link 01/2023 - 03/2016
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 09/2012
5	Sunitinib (Sutent)FDA Link 10/2021 - 03/2016
4	Bevacizumab (Avastin)FDA Link 01/2023 - 11/2013
4	olaparibIBA 01/2023 - 05/2017
4	Prostate-Specific Antigen (Semenogelase)IBA 12/2021 - 07/2009
4	cabozantinibIBA 01/2021 - 02/2013
4	Hormones (Hormone)IBA 01/2021 - 12/2005
3	NivolumabIBA 11/2023 - 05/2015
3	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 05/2015
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
3	Circulating Tumor DNAIBA 01/2022 - 01/2018
3	enzalutamideIBA 10/2021 - 05/2015
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2021 - 05/2015
2	taxaneIBA 03/2024 - 12/2005
2	gedatolisibIBA 01/2023 - 01/2023
2	cediranib (AZD2171)IBA 01/2023 - 01/2021
2	atezolizumabIBA 01/2023 - 01/2017
2	Abiraterone AcetateIBA 12/2021 - 11/2017
2	angiokinesIBA 06/2021 - 01/2021
2	AntigensIBA 01/2021 - 01/2017
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 03/2016
2	Cell-Free Nucleic AcidsIBA 10/2020 - 01/2018
2	IpilimumabIBA 12/2019 - 05/2017
2	Therapeutic UsesIBA 10/2019 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 02/2013
2	B7-H1 AntigenIBA 01/2017 - 02/2015
2	Gemcitabine FDA Link 08/2015 - 09/2014
2	Interleukin-2 (IL2)IBA 02/2015 - 11/2013
2	satraplatin (JM 216)IBA 01/2014 - 11/2009
2	Thalidomide (Thalomid)FDA Link 11/2007 - 02/2007
2	InterferonsIBA 11/2007 - 02/2007
1	CreatinineIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 09/2023
1	pembrolizumabIBA 01/2023
1	dacomitinibIBA 01/2023
1	trametinibIBA 02/2022
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 12/2021
1	erdafitinibIBA 12/2021
1	antiarrhythmic peptide (AAP)IBA 12/2021
1	Prednisone (Sone)FDA LinkGeneric 12/2021
1	sacituzumab govitecanIBA 12/2021
1	enfortumab vedotinIBA 12/2021
1	Testosterone (Sustanon)FDA Link 12/2021
1	GSK2636771IBA 10/2021
1	Recombinant DNA (Recombinant DNA Research)IBA 03/2021
1	ChromatinIBA 02/2021
1	bicalutamide (Casodex)FDA LinkGeneric 01/2021
1	VaccinesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	lenvatinibIBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	LigandsIBA 01/2019
1	avelumabIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2018

Therapy/Procedure

38	Therapeutics 01/2024 - 10/2005
15	Drug Therapy (Chemotherapy) 11/2023 - 12/2005
8	Castration 03/2024 - 02/2013
7	Nephrectomy 01/2023 - 08/2006
4	Adjuvant Chemotherapy 12/2020 - 01/2018
3	Radiotherapy 11/2023 - 05/2017
3	Neoadjuvant Therapy 10/2020 - 08/2015
2	Immunotherapy 01/2023 - 01/2021
2	Cystectomy 12/2020 - 08/2015
1	Combination Drug Therapy (Combination Chemotherapy) 12/2021
1	Prostatectomy (Retropubic Prostatectomy) 12/2021
1	Urinary Diversion (Ileal Conduit) 12/2020